Fellowship · La Jolla, CA
Sponsored by University of California (San Diego) Medical Center
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
The New England journal of medicine · 2024 · 227 citations · Sotirios Tsimikas
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a).
American heart journal · 2025 · 113 citations · Sotirios Tsimikas
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.
The New England journal of medicine · 2026 · 48 citations · Sotirios Tsimikas
SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions.
Journal of the Society for Cardiovascular Angiography & Interventions · 2024 · 122 citations · Mitul Patel
ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing.
Journal of the American College of Cardiology · 2025 · 84 citations · Ryan Reeves
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
Circulation · 2025 · 87 citations · Sotirios Tsimikas
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
The New England journal of medicine · 2024 · 172 citations · Sotirios Tsimikas
Oxidized phospholipids in cardiovascular disease.
Nature reviews. Cardiology · 2024 · 116 citations · Sotirios Tsimikas